• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟基脲相关性回盲瓣溃疡:因果关系证据

Hydroxyurea associated ileocecal valve ulcer: evidence for causality.

作者信息

Jayaraman Thevaraajan, Rajaram Ruveena Bhavani, Gan Gin Gin, Hilmi Ida

机构信息

Gastroenterology Unit, Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia.

Department of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.

出版信息

Intest Res. 2021 Oct;19(4):468-471. doi: 10.5217/ir.2020.00099. Epub 2020 Dec 1.

DOI:10.5217/ir.2020.00099
PMID:33249801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8566829/
Abstract

Hydroxyurea is an antimetabolite drug that is commonly used in many hematological disorders. Ulcer formation in the gastrointestinal tract is a rare phenomenon associated with this drug. We report a case of a 73-year-old woman who was found to have an isolated ileocecal valve ulcer while on hydroxyurea 1 g daily for essential thrombocythemia. A comprehensive evaluation ruled out all other causes. The cytoreductive therapy was switched to anagrelide and the endoscopic evaluation 6 months later showed complete healing of the ulcer. However, the hydroxyurea was resumed due to increasing platelet counts and intolerance to dose increments of the anagrelide. Subsequently, the patient was found to have a recurrence of the ulcer. Apart from oral ulcers, there have also been reports of ulcers involving the small bowel and the colon associated with the use of hydroxyurea. The pathophysiology of the non-oral gastrointestinal ulceration in relation to this drug is unclear. Withdrawal of the drug typically leads to complete resolution. Increasing awareness of the rare association between the use of hydroxyurea and nonoral gastrointestinal ulcers is essential for early detection to prevent related complications.

摘要

羟基脲是一种抗代谢药物,常用于多种血液系统疾病。胃肠道溃疡形成是与该药物相关的罕见现象。我们报告一例73岁女性病例,该患者因原发性血小板增多症每日服用1克羟基脲时,被发现有孤立的回盲瓣溃疡。全面评估排除了所有其他病因。细胞减灭治疗改为阿那格雷,6个月后的内镜评估显示溃疡完全愈合。然而,由于血小板计数增加以及对阿那格雷剂量增加不耐受,羟基脲又重新开始使用。随后,发现该患者溃疡复发。除口腔溃疡外,也有报道称使用羟基脲会导致小肠和结肠溃疡。与该药物相关的非口腔胃肠道溃疡的病理生理学尚不清楚。停药通常会使溃疡完全消退。提高对使用羟基脲与非口腔胃肠道溃疡之间罕见关联的认识,对于早期发现以预防相关并发症至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cd/8566829/c46bff4b5153/ir-2020-00099f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cd/8566829/87461367023e/ir-2020-00099f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cd/8566829/602de729582f/ir-2020-00099f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cd/8566829/c46bff4b5153/ir-2020-00099f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cd/8566829/87461367023e/ir-2020-00099f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cd/8566829/602de729582f/ir-2020-00099f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cd/8566829/c46bff4b5153/ir-2020-00099f3.jpg

相似文献

1
Hydroxyurea associated ileocecal valve ulcer: evidence for causality.羟基脲相关性回盲瓣溃疡:因果关系证据
Intest Res. 2021 Oct;19(4):468-471. doi: 10.5217/ir.2020.00099. Epub 2020 Dec 1.
2
Hydroxyurea-induced genital ulcers and erosions: Two case reports.羟基脲致生殖器溃疡和糜烂 2 例报告
J Tissue Viability. 2021 Aug;30(3):462-464. doi: 10.1016/j.jtv.2021.06.001. Epub 2021 Jun 6.
3
[Treatment outcome of patients with essential thrombocythemia at our department in Hungary].[匈牙利我们科室原发性血小板增多症患者的治疗结果]
Orv Hetil. 2016 Feb 28;157(9):336-41. doi: 10.1556/650.2016.30323.
4
Leg ulcers and hydroxyurea: report of three cases with essential thrombocythemia.腿部溃疡与羟基脲:三例原发性血小板增多症病例报告
Int J Dermatol. 2002 Dec;41(12):872-4. doi: 10.1046/j.1365-4362.2002.01623.x.
5
Repairing of recurrent leg ulcer induced by hydroxyurea with posterior tibial artery perforator propeller flap: Case report.
Int J Surg Case Rep. 2024 Jan;114:109049. doi: 10.1016/j.ijscr.2023.109049. Epub 2023 Nov 23.
6
Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis.在接受血液透析的患者中,使用安纳格雷德治疗难治性特发性血小板增多症。
Clin Ther. 2009 Nov;31(11):2559-64. doi: 10.1016/j.clinthera.2009.11.006.
7
[Essential thrombocythemia associated with incomplete type intestinal Behçet disease during hydroxyurea treatment].[羟基脲治疗期间与不完全型肠白塞病相关的原发性血小板增多症]
Rinsho Ketsueki. 2005 Oct;46(10):1136-40.
8
Leg ulcer in a patient associated with hydroxyurea therapy.一名接受羟基脲治疗的患者出现腿部溃疡。
Int J Dermatol. 2006 Feb;45(2):158-60. doi: 10.1111/j.1365-4632.2004.02450.x.
9
[A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].[原发性血小板增多症患者在羟基脲治疗期间出现的小腿溃疡]
Gan To Kagaku Ryoho. 1996 Jun;23(7):937-9.
10
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.羟基脲与阿那格雷治疗高危原发性血小板增多症的比较。
N Engl J Med. 2005 Jul 7;353(1):33-45. doi: 10.1056/NEJMoa043800.

引用本文的文献

1
Hydroxyurea-related ileocecal region ulcers as a rare complication: A case report.羟基脲相关的回盲部溃疡作为一种罕见并发症:一例报告
World J Clin Cases. 2025 Feb 26;13(6):94330. doi: 10.12998/wjcc.v13.i6.94330.
2
Esophageal and Ileal Ulcers Caused by Hydroxycarbamide: A Case Report and Literature Review.羟基脲引起的食管和回肠溃疡:一例报告及文献综述
Intern Med. 2025 Mar 15;64(6):845-849. doi: 10.2169/internalmedicine.4105-24. Epub 2024 Aug 10.

本文引用的文献

1
Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis.真性红细胞增多症和羟基脲耐药/不耐受:一项单中心回顾性分析。
Ann Hematol. 2019 Jun;98(6):1421-1426. doi: 10.1007/s00277-019-03654-6. Epub 2019 Mar 27.
2
Hydroxyurea-induced oral ulceration.羟基脲引起的口腔溃疡。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Dec;120(6):e232-4. doi: 10.1016/j.oooo.2015.09.006. Epub 2015 Sep 16.
3
Hydroxyurea and colonic ulcers: a case report.羟基脲与结肠溃疡:一例报告
BMC Gastroenterol. 2014 Jul 31;14:134. doi: 10.1186/1471-230X-14-134.
4
Oral lesions associated with hydroxyurea treatment.与羟基脲治疗相关的口腔病变
Indian J Dent Res. 2011 Nov-Dec;22(6):869-70. doi: 10.4103/0970-9290.94690.
5
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN.羟基脲相关毒性在 Ph'阴性 MPN 患者中的 3411 例研究。
Am J Hematol. 2012 May;87(5):552-4. doi: 10.1002/ajh.23160. Epub 2012 Apr 4.
6
Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera.欧洲白血病网络标准评估和预后价值在真性红细胞增多症中对羟基脲临床血液学反应、耐药性和不耐受性的评估和预后价值。
Blood. 2012 Feb 9;119(6):1363-9. doi: 10.1182/blood-2011-10-387787. Epub 2011 Dec 12.
7
Hydroxyurea: a key player in cancer chemotherapy.羟基脲:癌症化疗中的关键药物。
Expert Rev Anticancer Ther. 2012 Jan;12(1):19-29. doi: 10.1586/era.11.175.
8
Clinical evaluation of the European LeukaemiaNet criteria for clinicohaematological response and resistance/intolerance to hydroxycarbamide in essential thrombocythaemia.欧洲白血病网标准在原发性血小板增多症中对羟基脲临床血液学反应和耐药/不耐受的临床评估。
Br J Haematol. 2011 Jan;152(1):81-8. doi: 10.1111/j.1365-2141.2010.08430.x. Epub 2010 Nov 18.
9
Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients.羟基脲治疗骨髓纤维化过度增殖表现的疗效和耐受性:40 例患者的结果。
Ann Hematol. 2010 Dec;89(12):1233-7. doi: 10.1007/s00277-010-1019-9. Epub 2010 Jun 22.
10
Hydroxyurea and hydroxamic acid derivatives as antitumor drugs.羟基脲和异羟肟酸衍生物作为抗肿瘤药物。
Cancer Chemother Pharmacol. 2009 Jul;64(2):213-21. doi: 10.1007/s00280-009-0991-z. Epub 2009 Apr 7.